Finance

Lists
A1SN34:BVMF
Ascendis Pharma A/S Bdr
76,48 R$
0,00%
(0,00) 1D
5 հոկ, 16:02:32 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1SN34...
Mkt. cap
14,82 մլրդ
Avg. vol.
72,00
Volume
0,00
52-wk high
94,05 R$
52-wk low
70,00 R$
Shares outstanding
62,38 մլն
No. of employees
1 հզր
Mkt. cap
14,82 մլրդ
Avg. vol.
72,00
Volume
0,00
52-wk high
94,05 R$
52-wk low
70,00 R$
Shares outstanding
62,38 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
About Ascendis Pharma A/S Bdr
CEO-
Employees1,19 հզր
Founded2006
Headquarters-
Sector-
Websiteascendispharma.com
Last report
13 օգս, 2026 թ.
Fiscal period
Q2 2026
0,90 € / 0,77 €
+17,39%beat
Revenue / Est. (EUR)
339,28 մլն / 329,90 մլն
+2,84%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
213,63 մլն
247,50 մլն
246,60 մլն
339,28 մլն
Cost of goods sold
22,35 մլն
23,60 մլն
17,52 մլն
27,66 մլն
Cost of revenue
22,35 մլն
23,60 մլն
17,52 մլն
27,66 մլն
Research and development expenses
66,88 մլն
82,20 մլն
59,04 մլն
75,89 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
113,40 մլն
139,31 մլն
145,23 մլն
173,34 մլն
Operating expense
180,28 մլն
221,51 մլն
204,27 մլն
91,16 մլն
Total operating expenses
202,64 մլն
245,11 մլն
221,79 մլն
118,82 մլն
Operating income
11,00 մլն
2,39 մլն
24,81 մլն
220,46 մլն
Other non operating income
-
-105,57 մլն
-
-
EBT including unusual items
-57,37 մլն
-26,70 մլն
-48,18 մլն
230,09 մլն
EBT excluding unusual items
-57,37 մլն
-34,21 մլն
-48,18 մլն
230,09 մլն
Income tax expense
3,62 մլն
6,86 մլն
-677,52 մլն
23,12 մլն
Effective tax rate
-6,30%
-25,68%
1 406,31%
10,05%
Other operating expenses
-
-
-
-158,07 մլն
Net income
-60,99 մլն
-33,56 մլն
629,34 մլն
206,97 մլն
Net profit margin
-28,55%
-13,56%
255,21%
61,00%
Earnings per share
-1,00
-0,55
0,27
0,90
Interest and investment income
6,04 մլն
64,06 մլն
4,52 մլն
19,96 մլն
Interest expense
-66,90 մլն
-74,65 մլն
-67,26 մլն
-14,17 մլն
Net interest expenses
-60,87 մլն
-10,59 մլն
-62,74 մլն
5,79 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
15,02 մլն
3,60 մլն
29,03 մլն
225,03 մլն
Gain or loss from assets sale
-
-
-
21,00 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps